Related scientific articles (all)

The genomic landscape of breast cancer and its interaction with host immunity.

Authors : Luen S, Virassamy B, Savas P, Salgado R, Loi S
Year : 2016
Journal : Breast
Volume : 29
Pages : 241-50

Use of intraoperative radiation therapy in the conservative treatment of invasive male breast cancer.

Authors : Fromont A, Nogaret JM, De Neubourg F, Philippson C
Year : 2016
Journal : Rev Med Brux
Volume : 37(1)
Pages : 40-5

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Authors : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 103-11

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Authors : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Year : 2016
Journal : Sci Transl Med
Volume : 8
Pages : 369ra177

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

Authors : Hortobagyi GN, Chen D, Piccart-Gebhart M, Rugo HS, Burris HA 3rd, Pritchard KI, Campone M, Noguchi S, Perez AT, Deleu I, Shtivelband M, Masuda N, Dakhil S, Anderson I, Robinson DM, He W, Garg A, McDonald ER 3rd, Bitter H, Huang A, Taran T, Bachelot T, Lebrun F, Lebwohl D, Baselga J
Year : 2016
Journal : J Clin Oncol
Volume : 34(5)
Pages : 419-26

Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.

Authors : Brown DN, Caffa I, Cirmena G, Piras D, Garuti A, Gallo M, Alberti S, Nencioni A, Ballestrero A, Zoppoli G
Year : 2016
Journal : Sci Rep
Volume : 6
Pages : 19435

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Authors : Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, Van Velthoven R
Year : 2016
Journal : Scand J Urol
Volume : 50(3)
Pages : 144-8

Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.

Authors : Deliens C, Deliens G, Filleul O, Pepersack T, Awada A, Piccart-Gebhart M, Praet JP, Dal Lago L
Year : 2016
Journal : J Geriatr Oncol
Volume : 7(6)
Pages : 463-70

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy.

Authors : Tabchi S, Kourie HR, Kattan J
Year : 2016
Journal : Invest New Drugs
Volume : 34(6)
Pages : 794-6

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.

Authors : Loi S, Dafni U, Karlis D, Polydoropoulou V, Young BM, Willis S, Long B, de Azambuja E, Sotiriou C, Viale G, Rüschoff J, Piccart-Gebhart M, Dowsett M, Michiels S, Leyland-Jones B
Year : 2016
Journal : JAMA Oncol
Volume : 2(8)
Pages : 1040-7

Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

Authors : Van Praet C, Rottey S, Van Hende F, Pelgrims G, Demey W, Van Aelst F, Wynendaele W, Gil T, Schatteman P, Filleul B, Schallier D, Machiels JP, Schrijvers D, Everaert E, DHondt L, Werbrouck P, Vermeij J, Mebis J, Clausse M, Van Erps J, Verheezen J, Van Haverbeke J, Goeminne JC, Lumen N
Year : 2016
Journal : European urology supplements
Volume : 15(3)
Pages : -

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT0006

Authors : Tryfonidis K, Basaran G, Bogaerts J, Debled M, Dirix L, Thery JC, Tjan-Heijnen VC, Van den Weyngaert D, Cufer T, Piccart-Gebhart M, Cameron D
Year : 2016
Journal : Eur J Cancer
Volume : 53
Pages : 144-54

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.

Authors : VAN DEN Heuvel B, Peeters M, Hendlisz A, Van den Eynde M, Machiels G, Dero I, Geboes K, De Man M, Hendrickx K, Delaunoit T, Monsaert E, Vanderstraten E, Van Laethem JL, Lybaert W, Holbrechts S, Rolfo C
Year : 2016
Journal : Minerva Chir

Levator Ani Necrosis: An Exceptional Complication Occurring after High Intensity Focused Ultrasound" of the Prostate."

Authors : Badawy D, El Rassy E, Aoun F, Van Velthoven R
Year : 2016
Journal : Case Rep Urol
Volume : 2016
Pages : 3920976

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Authors : Sideris S, Aoun F, Zanaty M, Martinez NC, Latifyan S, Awada A, Gil T
Year : 2016
Journal : Mol Clin Oncol
Volume : 4
Pages : 1063-1067

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.

Authors : Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC, Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard KI, McCullough AE, Dolci S, Mcfadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Suter T, Gelber Rd, Perez EA
Year : 2016
Journal : J Clin Oncol
Volume : 34(10)
Pages : 1034-42

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Authors : Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D
Year : 2016
Journal : PLoS One
Volume : 11
Pages : e0159734

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.

Authors : Brouwers B, Hatse S, Dal Lago L, Neven P, Vuylsteke P, Dalmasso B, Debrock G, Van den Bulck H, Smeets A, Bechter O, Kini Bailur J, Kenis C, Laenen A, Schöffski P, Pawelec G, Journe F, Ghanem G, Wildiers H
Year : 2016
Journal : Oncotarget
Volume : 7(21)
Pages : 29977-88

Guidance for the prevention and treatment of venous thromboembolism in cancer patients

Authors : Awada A, Baurain JF, Clement P, Hainaut P, Holbrechts S, Hougardy JM, Jochmans K, Mathieu V, Mebis J, Strijbos MH, Vulsteke C, Verheij M
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 7(6)
Pages : 217-23

Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design.

Authors : Kourie HR, Aoun F
Year : 2016
Journal : Invest New Drugs
Volume : 34(4)
Pages : 513-4